DoD Prostate Cancer Research Program anticipated funding opportunities for FY23

DOD Kidney Cancer Research Program funding opportunities for FY24

The FY24 Defense Appropriations Act provides funding for the Kidney Cancer Research Program to support research of exceptional scientific merit in the area of kidney cancer.

April 19, 2024

Vol.50 No.16

Clinical Roundup

Urine test improves non-invasive detection of prostate cancer

A urine test that measures 18 genes associated with prostate cancer provides higher accuracy for detecting clinically significant cancers than PSA and other existing biomarker tests, according to a study published April 18 in JAMA Oncology.

April 19, 2024

Vol.50 No.16

NCI Director's Report

Rathmell: To improve funding outlook, we must reverse distrust in science

With NCI funding expected to remain flat through fiscal year 2025, health professionals and leaders in oncology should use this time to amp up institutional efforts to collaborate and rebuild trust in science, NCI Director Kimryn Rathmell said.

April 12, 2024

Vol.50 No.15

By Matthew Bin Han Ong

Funding Opportunities

DOD Lung Cancer Research Program funding opportunities for FY24

The FY24 Defense Appropriations Act provides funding for the LCRP to support innovative, high-impact lung cancer research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.

April 12, 2024

Vol.50 No.15